Other languages Codexis, Inc.

Equities

CDXS

US1920051067

Real-time Estimate Cboe BZX Other stock markets 10:16:31 2024-04-16 am EDT			5-day change	1st Jan Change
2.68 ^USD	-0.37%		-18.58%	-13.77%

Apr. 11	Codexis, Inc. Appoints Carole Cobb to Its Strategic Advisory Board	CI
Feb. 29	Benchmark Upgrades Codexis to Buy From Hold, Price Target is $9	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Codexis, Inc. Appoints Carole Cobb to Its Strategic Advisory Board	Apr. 11
Codexis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche	Feb. 26
Ausblick Nestlé: Organisches Wachstum von 7,3 Prozent erwartet	Feb. 21
Prévisions Nestlé: croissance organique attendue à 7,3%	Feb. 21
Codexis, Inc Appoints Masad Damha, PhD and Jim Lalonde, PhD to Strategic Advisory Board	Feb. 20
Codexis, Inc. Announces Not to Stand for Reelection of Jennifer Aaker as Board of Director	Feb. 16
SeqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting	Feb. 01
Swiss Shares Decline Amid Lingering Concerns for Growth of Local Economy	Dec. 27
Nestlé Unit to Buy Codexis’ Pancreatic Condition Therapy for Up to $45 Million	Dec. 27
Nestlé Health Science achète un candidat produit de Codexis	Dec. 27
Nestlé Health Science übernimmt Produktkandidat von Protein-Entwickler Codexis	Dec. 27
Codexis, Inc. Announces Purchase Agreement with Nestle Health Science for Cdx-7108	Dec. 27
Bourse Zurich: en rouge à l'entame de la dernière semaine de l'année	Dec. 27
Codexis Assigns Interests in Potential Exocrine Pancreatic Insufficiency Treatment to Nestle Health Science	Dec. 27
Top Midday Gainers	Dec. 14
Federal Reserve Outlook Pushes Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday	Dec. 14
Codexis Signs Exclusive License Agreement With Aldevron for Codex HiCap RNA Polymerase; Shares Surge Premarket	Dec. 14
Codexis Signs Exclusive License Agreement With Aldevron for Codex HiCap RNA Polymerase	Dec. 13
Codexis, Inc. and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase	Dec. 13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Codexis, Inc.

Equities

CDXS

US1920051067

Other languages

Filters